Chronic Pain and Opioid Use Disorder: Coordinating Safe Treatment

This article explains how clinicians coordinate care for people with chronic pain and opioid use disorder, including medications, pain management, and safety steps. Placement and medication choices require evaluation by

Many people and families facing ongoing pain also worry about problematic opioid use. Managing chronic pain while treating opioid use disorder requires careful, coordinated care that treats both conditions, reduces overdose risk, and preserves function. This article explains common approaches, what to expect from clinicians, and how outpatient programs may work with your medical and pain teams. Placement and medication decisions require individualized assessment by a qualified clinician.

Table of Contents

Why coordinated care matters

Chronic pain and opioid use disorder often occur together. Treating one condition while ignoring the other can increase the risk of continued pain, return to nonprescribed opioid use, overdose, or avoidable withdrawal. National clinical guidance encourages clinicians to assess both pain and substance use, use medications for opioid use disorder when appropriate, and offer naloxone and additional monitoring for safety. (cdc.gov)

Medications and how they fit with chronic pain

Medications for opioid use disorder, sometimes called MOUD, include buprenorphine, methadone, and extended release naltrexone. These medications reduce cravings and withdrawal, and they are associated with lower risk of overdose and death when used as part of a treatment plan. Decisions about which medication, and how it should be integrated with pain management, are clinical decisions made after a full assessment. (fda.gov)

Medication	How it works	Typical outpatient setting	Pain considerations	Key risks
Buprenorphine	Partial opioid agonist, reduces craving and withdrawal	Primary care, addiction clinics, office-based MOUD	May provide analgesia; doses and split dosing can be adjusted with clinician input	Precipitated withdrawal if started too soon after other opioids; interactions with sedatives
Methadone	Full opioid agonist, scheduled dosing stabilizes OUD	Opioid treatment programs (OTP) with daily dispensing	Effective analgesic when managed in specialty settings; additional pain dosing sometimes needed for acute pain	Respiratory depression risk; requires regulated clinic visits and careful monitoring
Extended release naltrexone	Opioid antagonist, blocks opioid effects	Specialty clinics, some outpatient programs	Requires opioid abstinence before initiation, so not suitable for people who need ongoing opioid analgesia	Precipitated withdrawal if given to someone with opioids on board; return to risk if opioids are resumed after blockade

Summary comparisons like the table above are a starting point. Individual factors matter: recent opioid use, medical comorbidities, pregnancy, liver disease, access to clinics, insurance rules, and personal goals all influence medication choice. The American Society of Addiction Medicine and federal guidance emphasize individualized assessment and flexible, patient centered planning for people with coexisting pain and OUD. (asam.org)

Integrating nonmedication pain strategies

Effective chronic pain care usually combines approaches. Nonpharmacologic therapies include physical therapy, cognitive behavioral therapy for pain, interventional procedures when indicated, sleep and activity management, and appropriate use of nonopioid medications. The 2022 CDC clinical practice guideline for opioid prescribing recommends offering or prioritizing nonopioid treatments for many types of chronic pain and counseling about risks when opioids are considered. When opioids are part of care, clinicians should offer naloxone and increased monitoring. (cdc.gov)

Common clinical pathways in outpatient programs

Outpatient addiction and pain clinicians usually coordinate in one of these ways:

Primary care or pain clinic manages chronic pain while consulting with addiction specialists about safe opioid tapering and MOUD initiation.
An addiction treatment program provides MOUD and works with the patients pain providers on cross-coverage, objective monitoring, and shared goals.
Joint programs or collaborative networks provide co-located or closely coordinated treatment for both conditions.

Telehealth and updated federal and state rules have improved access to buprenorphine and other services in many areas. New Jersey has recently adjusted rules to expand access to MOUD and harm reduction, which can increase local treatment options. Ask your program about coordination with your pain clinician and about state-level changes that affect care. (samhsa.gov)

Safety steps and overdose prevention

Safety notice: For a medical emergency, call 911. For a mental health or suicide crisis, call or text 988. If you use opioids, ask your clinician to provide naloxone and training in how to use it. Clinicians should also review other overdose risks, such as combining opioids with benzodiazepines or heavy alcohol use, and consider closer monitoring when those risks are present. (cdc.gov)

What to expect when starting MOUD with chronic pain

Typical elements of an outpatient plan include:

Comprehensive assessment of pain, substance use history, mental health, and medical risks.
Shared discussion of treatment goals, including pain control, function, and relapse prevention.
Selection of a medication for OUD if indicated, with clear instructions, monitoring plans, and coordination with pain prescribers.
Nonopioid pain treatments and behavioral supports to improve coping and function.
Safety measures such as naloxone, urine drug testing when clinically appropriate, and frequent follow up early in treatment. (nida.nih.gov)

Practical note about starting buprenorphine

When buprenorphine is started, clinicians usually wait until the person is in mild to moderate withdrawal if the patient has recently used full opioid agonists. This reduces the risk of precipitated withdrawal. In some urgent settings, clinicians have begun buprenorphine safely in the emergency department with handoff to outpatient care, and research shows ED initiation improves linkage to ongoing treatment. Discuss timing and setting with your clinician. (nida.nih.gov)

When to seek higher level or specialized care

Certain situations require urgent or specialist care, including pregnancy, adolescents or young adults, severe or complicated withdrawal, seizures, psychosis, suspected overdose, uncontrolled medical problems, or high suicide risk. For these situations, immediate transfer or referral to specialized addiction medicine, obstetric, pediatric, or hospital-based services is appropriate. Providers should not delay higher level care when these risks are present. (asam.org)

Frequently asked questions

Can I keep my pain medicine if I start treatment for opioid use disorder?

That depends on the medication and clinical situation. Methadone and buprenorphine can provide some analgesia and may be continued or adjusted. Extended release naltrexone blocks opioid effects and requires opioid abstinence before starting, so it is usually not used when ongoing opioid analgesia is needed. A clinician will review risks and alternatives with you. (fda.gov)

Will I have to stop all opioids to start treatment?

Not always. Buprenorphine initiation usually requires a short period of withdrawal from full opioid agonists to avoid precipitated withdrawal. Methadone is started in opioid treatment programs with specialized monitoring and may continue to provide pain control. Naltrexone requires abstinence for a longer period before initiation. A qualified clinician will design a safe timing and transition plan. (nida.nih.gov)

Is medication the only treatment recommended?

No. Medications are effective at reducing overdose risk and treating OUD symptoms, but best outcomes come from combining medication with pain management, behavioral therapies, physical rehabilitation, and social support. Treatment plans should be individualized. (nida.nih.gov)

Sources and further reading

Next steps and contacts

This information is educational and not personalized medical advice. If you or a family member has chronic pain and concerns about opioid use, talk with a qualified clinician who can perform a thorough assessment and recommend an individualized plan. If you are looking for outpatient services that coordinate pain and addiction care, you may find information about available programs and treatments at our treatments and locations pages, or contact our admissions team for assistance. Please call 911 in a medical emergency, and call or text 988 for a mental health or suicide crisis.

See treatment options | Find a location | Contact admissions

To request a confidential assessment or to speak with the admissions team about coordinated chronic pain and opioid use disorder treatment, please reach out using our contact page. We will answer questions about intake steps, but placement and medication choices require evaluation by a licensed clinician and individualized care planning.